Dennis Turpin - Net Worth and Insider Trading
Dennis Turpin Net Worth
The estimated net worth of Dennis Turpin is at least $166,400 dollars as of 2024-09-30. Dennis Turpin is the Director of Cosciens Biopharma Inc and owns about 32,000 shares of Cosciens Biopharma Inc (TSX:CSCI) stock worth over $166,400. Details can be seen in Dennis Turpin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis Turpin has not made any transactions after 2022-01-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis Turpin
Dennis Turpin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Turpin owns 1 companies in total, including Cosciens Biopharma Inc (TSX:CSCI) .
Click here to see the complete history of Dennis Turpin’s form 4 insider trades.
Insider Ownership Summary of Dennis Turpin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:CSCI | Cosciens Biopharma Inc | 2022-01-06 | Director |
Dennis Turpin Latest Holdings Summary
Dennis Turpin currently owns a total of 1 stock. Dennis Turpin owns 32,000 shares of Cosciens Biopharma Inc (TSX:CSCI) as of January 6, 2022, with a value of $166,400.
Latest Holdings of Dennis Turpin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:CSCI | Cosciens Biopharma Inc | 2022-01-06 | 32,000 | 5.20 | 166,400 |
Holding Weightings of Dennis Turpin
Dennis Turpin Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Turpin has made a total of 1 transactions in Cosciens Biopharma Inc (TSX:CSCI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cosciens Biopharma Inc is the acquisition of 32,000 shares on January 6, 2022, which cost Dennis Turpin around $745,763.
Insider Trading History of Dennis Turpin
- 1
Dennis Turpin Trading Performance
GuruFocus tracks the stock performance after each of Dennis Turpin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis Turpin is -5.45%. GuruFocus also compares Dennis Turpin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis Turpin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis Turpin's insider trading performs compared to the benchmark.
Performance of Dennis Turpin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.64 | | | | | |
| Relative Return to S&P 500(%) | -9.48 | | | | | |
Dennis Turpin Ownership Network
Dennis Turpin Owned Company Details
What does Cosciens Biopharma Inc do?
Who are the key executives at Cosciens Biopharma Inc?
Dennis Turpin is the Director of Cosciens Biopharma Inc.
Cosciens Biopharma Inc (TSX:CSCI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cosciens Biopharma Inc (TSX:CSCI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cosciens Biopharma Inc (TSX:CSCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cosciens Biopharma Inc (TSX:CSCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cosciens Biopharma Inc Insider Transactions
Dennis Turpin Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Turpin. Currently GuruFocus does not have mailing address information for Dennis Turpin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
